Quantitative longitudinal mapping of radiation-treated prostate cancer using MR fingerprinting with radial acquisition and subspace reconstruction.
MR fingerprinting
Prostate cancer
Quantitative parameter mapping
Radiation therapy
Subspace reconstruction
Journal
Magnetic resonance imaging
ISSN: 1873-5894
Titre abrégé: Magn Reson Imaging
Pays: Netherlands
ID NLM: 8214883
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
01
02
2023
accepted:
29
03
2023
pmc-release:
01
09
2024
medline:
26
4
2023
pubmed:
5
4
2023
entrez:
4
4
2023
Statut:
ppublish
Résumé
MR fingerprinting (MRF) enables fast multiparametric quantitative imaging with a single acquisition and has been shown to improve diagnosis of prostate cancer. However, most prostate MRF studies were performed with spiral acquisitions that are sensitive to B0 inhomogeneities and consequent blurring. In this work, a radial MRF acquisition with a novel subspace reconstruction technique was developed to enable fast T1/T2 mapping in the prostate in under 4 min. The subspace reconstruction exploits the extensive temporal correlations in the MRF dictionary to pre-compute a low dimensional space for the solution and thus reduce the number of radial spokes to accelerate the acquisition. Iterative reconstruction with the subspace model and additional regularization of the signal representation in the subspace is performed to minimize the number of spokes and maintain matching quality and SNR. Reconstruction accuracy was assessed using the ISMRM NIST phantom. In-vivo validation was performed on two healthy subjects and two prostate cancer patients undergoing radiation therapy. The longitudinal repeatability was quantified using the concordance correlation coefficient (CCC) in one of the healthy subjects by repeated scans over 1 year. One prostate cancer patient was scanned at three time points, before initiating therapy and following brachytherapy and external beam radiation. Changes in the T1/T2 maps obtained with the proposed method were quantified. The prostate, peripheral and transitional zones, and visible dominant lesion were delineated for each study, and the statistics and distribution of the quantitative mapping values were analyzed. Significant image quality improvements compared with standard reconstruction methods were obtained with the proposed subspace reconstruction method. A notable decrease in the spread of the T1/T2 values without biasing the estimated mean values was observed with the subspace reconstruction and agreed with reported literature values. The subspace reconstruction enabled visualization of small differences in T1/T2 values in the tumor region within the peripheral zone. Longitudinal imaging of a volunteer subject yielded CCC of 0.89 for MRF T1, and 0.81 for MRF T2 in the prostate gland. Longitudinal imaging of the prostate patient confirmed the feasibility of capturing radiation treatment related changes. This work is a proof-of-concept for a high resolution and fast quantitative mapping using golden-angle radial MRF combined with a subspace reconstruction technique for longitudinal treatment response assessment in subjects undergoing radiation treatment.
Identifiants
pubmed: 37015305
pii: S0730-725X(23)00064-4
doi: 10.1016/j.mri.2023.03.019
pmc: PMC10623548
mid: NIHMS1940126
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
25-34Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA262662
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest This work was performed as part of a master research agreement between MSKCC and Philips Healthcare. MB, MD, PM, and PK were employees of Philips Healthcare while making contributions to this work.
Références
Radiology. 2017 Jun;283(3):729-738
pubmed: 28187264
Magn Reson Med. 2007 Dec;58(6):1182-95
pubmed: 17969013
Magn Reson Med. 2017 Nov;78(5):1781-1789
pubmed: 28074530
J Magn Reson Imaging. 2020 Mar;51(3):675-692
pubmed: 31264748
Magn Reson Med. 2019 Jun;81(6):3530-3543
pubmed: 30720209
IEEE Trans Biomed Eng. 2014 Sep;61(9):2451-7
pubmed: 24801352
Magn Reson Med. 2015 Dec;74(6):1621-31
pubmed: 25491018
Magn Reson Med. 2022 Oct;88(4):1818-1827
pubmed: 35713379
Radiographics. 2018 Mar-Apr;38(2):437-449
pubmed: 29373089
IEEE Trans Med Imaging. 2014 Dec;33(12):2311-22
pubmed: 25029380
CA Cancer J Clin. 2022 Sep;72(5):409-436
pubmed: 35736631
J Magn Reson Imaging. 2022 Jul;56(1):45-62
pubmed: 35396897
Magn Reson Med. 2010 Sep;64(3):767-76
pubmed: 20535813
Magn Reson Med. 2021 Sep;86(3):1194-1211
pubmed: 33847012
Invest Radiol. 2019 Aug;54(8):485-493
pubmed: 30985480
IEEE Trans Med Imaging. 2010 Jan;29(1):196-205
pubmed: 19923044
Magn Reson Med. 2014 Sep;72(3):707-17
pubmed: 24142845
IEEE Trans Med Imaging. 2007 Jan;26(1):68-76
pubmed: 17243585
Magn Reson Med. 2015 Aug;74(2):523-8
pubmed: 25168690
Magn Reson Med. 2018 Apr;79(4):2392-2400
pubmed: 28804918
Magn Reson Med. 2018 Jan;79(1):83-96
pubmed: 28261851
MAGMA. 2022 Aug;35(4):557-571
pubmed: 35419668
Nature. 2013 Mar 14;495(7440):187-92
pubmed: 23486058
Magn Reson Med. 2013 Jan;69(1):71-81
pubmed: 22378141
J Magn Reson Imaging. 2019 Sep;50(3):810-815
pubmed: 30584691
Radiology. 2014 May;271(2):452-60
pubmed: 24495265
Magn Reson Med. 2017 Oct;78(4):1452-1457
pubmed: 27790751
Radiology. 2019 Sep;292(3):685-694
pubmed: 31335285
Biometrics. 1989 Mar;45(1):255-68
pubmed: 2720055
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566
Sci Rep. 2020 Nov 24;10(1):20475
pubmed: 33235229
Phys Med Biol. 2001 Mar;46(3):R1-45
pubmed: 11277237
Med Phys. 2018 Jul 4;:
pubmed: 29972693